Author Correction: Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cell.
Nature immunology
View this publicationNature immunology
View this publicationLung cancer (Amsterdam, Netherlands)
View this publicationNature immunology
View this publicationCancer research
View this publicationMolecular therapy : the journal of the American Society of Gene Therapy
View this publicationEuropean urology oncology
View this publicationClinical & translational immunology
View this publicationJAMA oncology
View this publicationImmunology and cell biology
View this publicationNature communications
View this publication